Get all premium features to the best stock analysis tool

Hikma Pharmaceuticals PLC (HKMPY) Q2 2026 Earnings Call Transcript

Hikma Pharmaceuticals PLC (HKMPY) Q2 2026 Earnings Call Prepared Remarks Transcript

Hikma Pharmaceuticals LON: HIK said it reiterated its full-year guidance after reporting higher sales, earnings and per-share profit in its 2026 interim results, while outlining further investment in manufacturing capacity, research and development, and commercial capabilities.